<code id='0DC20120F1'></code><style id='0DC20120F1'></style>
    • <acronym id='0DC20120F1'></acronym>
      <center id='0DC20120F1'><center id='0DC20120F1'><tfoot id='0DC20120F1'></tfoot></center><abbr id='0DC20120F1'><dir id='0DC20120F1'><tfoot id='0DC20120F1'></tfoot><noframes id='0DC20120F1'>

    • <optgroup id='0DC20120F1'><strike id='0DC20120F1'><sup id='0DC20120F1'></sup></strike><code id='0DC20120F1'></code></optgroup>
        1. <b id='0DC20120F1'><label id='0DC20120F1'><select id='0DC20120F1'><dt id='0DC20120F1'><span id='0DC20120F1'></span></dt></select></label></b><u id='0DC20120F1'></u>
          <i id='0DC20120F1'><strike id='0DC20120F1'><tt id='0DC20120F1'><pre id='0DC20120F1'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          comprehensive

          author:fashion    - browse:8
          Christine Kao/STAT

          There’s a specter haunting Wall Street.

          It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

          advertisement

          Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time